PlainRecalls
CriticalClass ITerminated

FDA Drug recall · Reported April 16, 2014

Vicerex A Powerful And Fast Acting Male Sexual Enhancer, 10 capsules per box, Dietary Supplement. UPC 893490820087 (product numbers may possibly vary for same product identification and same product packaging), distributed by Vicerex.com.

Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains…

Recall #
D-1223-2014
Affected scope
13 boxes distributed domestically & 50 boxes distributed internationally to consumers
Initiated
April 30, 2013
Verify with FDA Drug →
View my saved recalls

American Lifestyle.Com recalled Vicerex A Powerful And Fast Acting Male Sexual Enhancer, 10 capsules per box, Dietary Sup… - a critical-severity action.

Vicerex A Powerful And Fast Acting Male Sexual Enhancer, 10 capsules per box, Dietary Sup… was recalled by American Lifestyle.Com in April 16, 2014. Reason: Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex pr…. Check the official notice for the remedy. Verify recall #D-1223-2014 with the FDA Drug before acting.

The recall

American Lifestyle.Com issued this critical-severity FDA Drug recall-Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex pr….

Critical
severity level
Class I
classification
April 16, 2014
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-1223-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-1223-2014) was formally reported on April 16, 2014, with the manufacturer initiating the action on April 30, 2013. It is classified under Critical severity (Class I), with a current status of Terminated. American Lifestyle.Com is listed as the recalling firm, operating out of Pittsford, NY. Federal records list the affected scope as 13 boxes distributed domestically & 50 boxes distributed internationally to consumers.

The documented reason for this recall is: Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil. Tadalafil and … Distribution data in the federal record shows the product reached: Domestic distribution currently under Investigation; International distribution includes, but may not be limited to the following countries : Mexico, France, Brazil, Belgium, Denmark, Switzerland, Spain, Canada, Italy, …. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Dietary Supplements recalls over time

Where this recall sits in its category - 2,002 dietary supplements recalls on record

-1000100200300400 20072010201320162019202220252026 9
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Critical

Affected scope

13 boxes distributed domestically & 50 boxes distributed internationally to consumers

Related Recalls

6

0 from same agency

Product description

Vicerex A Powerful And Fast Acting Male Sexual Enhancer, 10 capsules per box, Dietary Supplement. UPC 893490820087 (product numbers may possibly vary for same product identification and same product packaging), distributed by Vicerex.com.

Reason for recall

Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil. Tadalafil and sildenafil are FDA-Approved drugs used to treat male erectile dysfunction (ED), making the Vicerex and the Black Ant products unapproved new drugs.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Critical (Class I)
Status Terminated
Recall number D-1223-2014
Date reported April 16, 2014
Date initiated April 30, 2013
Recalling firm American Lifestyle.Com
Firm location Pittsford, NY
Affected scope 13 boxes distributed domestically & 50 boxes distributed internationally to consumers
Distribution Domestic distribution currently under Investigation; International distribution includes, but may not be limited to the following countries : Mexico, France, Brazil, Belgium, Denmark, Switzerland, Spain, Canada, Italy, Japan, Ireland, Vene…

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-1223-2014) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Vicerex A Powerful And Fast Acting Male Sexual Enhancer, 10 capsules per box, Dietary Supplement. UPC 893490820087 (product numbers may possibly vary for same product identification and same product packaging), distributed by Vicerex.com.. Recalled by American Lifestyle.Com. Units affected: 13 boxes distributed domestically & 50 boxes distributed internationally to consumers.
Why was this product recalled?
Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil. Tadalafil and sildenafil are FDA-Approved drugs used to treat male erectile dysfunction (ED), making the Vicerex and the Black Ant products unapproved new drugs.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 16, 2014. Severity: Critical. Recall number: D-1223-2014.
Where was the recalled product distributed?
Distribution: Domestic distribution currently under Investigation; International distribution includes, but may not be limited to the following countries : Mexico, France, Brazil, Belgium, Denmark, Switzerland, Spain, Canada, Italy, Japan, Ireland, Venezuela, Oman..
How do I check if my product is affected by a recall?
Check the product description and recall number (D-1223-2014) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Blue Bull Extreme Male Enhancement Supplement, total of 15 … →

Browse all Dietary Supplements recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported April 16, 2014. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.